# FDA 483 - Curia Global, Inc. - January 15, 2019

Source: https://www.keypedia.com/records/483/curia-global-inc/5cfbda0c-9556-45f8-8815-66bc57da39dd

> FDA 483 for Curia Global, Inc. on January 15, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Curia Global, Inc.
- Inspection Date: 2019-01-15
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: Albany Molecular Research Inc. in Albany, NY, a manufacturer and controlled testing lab, received a Form 483 with four observations. The inspection revealed deficiencies primarily related to inadequate cleaning procedures, failures in following quality control unit responsibilities, and issues with inventory/warehouse systems and batch production records. These observations indicate a lack of adherence to established procedures and potential risks to product quality and traceability.

## Related Documents

- [483 - 2025-05-09](https://www.keypedia.com/records/483/curia-global-inc/955787bf-f8bf-4e33-bc9c-54878e62cb07)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)

Company: https://www.keypedia.com/companies/curia-global-inc/70463a22-7e8e-48fc-9c8d-f781da625c4c

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961